Maryland Medical Assistance Program and Health Insurance - Coverage and Utilization Review - Drugs Reviewed by the Prescription Drug Affordability Board
Hearing (Senate)
Email me when SB 837 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track SB 837. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill stops managed‑care organizations, insurers, nonprofit health plans and HMOs from using prior authorizations, step‑therapy or fail‑first rules on prescription drugs that the Prescription Drug Affordability Board (PDAB) has reviewed, when the board has not flagged an affordability problem, has issued a policy recommendation, or has set an upper payment limit. It also limits how these entities can limit, restrict, or remove such drugs from their formularies. The changes aim to improve patient access to affordable medicines.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about SB 837
3 free questions a day, no accountHearings
- Finance — Bill HearingFinance · Mar 4, 2026
History
- Hearing 3/04 at 1:00 p.m.
- First Reading Finance
Sponsors
- Ready · sponsor
- Lam
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when SB 837 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track SB 837 freeOr ask your AI assistant about SB 837 directly:
Add to Claude, ChatGPT or Cursor